Schedule 13G ownership disclosure

Cytokinetics Inc

COMMON STOCK · CUSIP: 23282W605

Event date: 2025-07-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 13,101,596.22 · Class: 10.9%

  • Abigail P. Johnson

    Shares: 13,101,596.22 · Class: 10.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-25-002178
Form type
SCHEDULE 13G/A
Filer
CYTOKINETICS INC
CIK
CIK 1061983
Filed
Aug 07, 2025
Reporting period
Jul 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub